Tags : FDA

Medicilon Assist - The IND application for the first new drug NB002 of Neologics Bioscience was appr

Medicilon Assist - The IND application for the fir..

A Story by Medicilon


Recently, Neologics Bioscience announced that its research and development pipeline NB002 for the treatment of solid tumors has successfully passed th..
Medicilon Assisted - The IND application of BIOT-001, the first self-developed new drug of Biotime B

Medicilon Assisted - The IND application of BIOT-0..

A Story by Medicilon


On July 14, the IND application for the BIOT-001 project targeting the S1P1 target declared by Biotime Biotechnology obtained the US FDA's clinical im..
Testing leader ALS offers insight on new FDA MoCRA budget targeting PFAS in cosmetics

Testing leader ALS offers insight on new FDA MoCRA..

A Story by 1888pressrelease


(1888PressRelease) The US FDA has requested $8M to support the implementation of MoCRA. including the assessment of PFAS in cosmetic products. With en..